{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:00:23Z","timestamp":1771059623017,"version":"3.50.1"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>To harmonize with the EUCAST breakpoints, the French Society of Microbiology introduced a change in the inhibition diameter breakpoint (17\u2005mm versus 20\u2005mm previously) of temocillin. We assessed the impact of the new breakpoints on categorizing susceptibility of Enterobacterales to temocillin.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a multicentric retrospective study including all Enterobacterales isolates routinely tested for temocillin susceptibility with the disc diffusion method between 1 January 2016 and 31 July 2022 in four centres. Categorization using the breakpoints of 20\u2005mm (French guidelines CA-SFM\/EUCAST 2020 v.1.1) and 17\u2005mm (French guidelines CA-SFM\/EUCAST 2021 v1.0 and EUCAST guidelines v11.0) was performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, 36\u200a416 Enterobacterales isolates were included. The overall rate of temocillin resistance decreased from 11.3% to 4.7% (relative difference of 58.5%) when using the 17\u2005mm breakpoint instead of the 20\u2005mm breakpoint, respectively. The relative change ranged from \u221244.0% in Klebsiella aerogenes to \u221272.7% in Klebsiella oxytoca. The median inhibition diameter was 23\u2005mm (IQR 21\u201325). The isolates with a diameter of 20\u2005mm appeared overrepresented, whereas those with a diameter of 18 and 19\u2005mm were underrepresented. We therefore reviewed the diameters between 18 and 21\u2005mm of 273 isolates. Thirty-two (11.7%) of them categorized as susceptible at first measure were controlled resistant at second measure.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The new breakpoint induced a decrease in the rate of isolates categorized as resistant to temocillin, increasing therapeutic choice including for Extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-PE). We suggest the bias in measuring the inhibition diameter is probably related to the fact that temocillin is considered remarkably stable against broad-spectrum \u03b2-lactamases.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jacamr\/dlad114","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T20:42:32Z","timestamp":1699303352000},"source":"Crossref","is-referenced-by-count":2,"title":["Impact of revised breakpoints on the categorization of susceptibility of Enterobacterales to temocillin"],"prefix":"10.1093","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3243-8018","authenticated-orcid":false,"given":"Eric","family":"Farfour","sequence":"first","affiliation":[{"name":"Service de Biologie Clinique, H\u00f4pital Foch , Suresnes , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9846-0210","authenticated-orcid":false,"given":"C\u00e9cile","family":"Le Brun","sequence":"additional","affiliation":[{"name":"Service de Microbiologie, CHU Bretonneau , Tours , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7131-9882","authenticated-orcid":false,"given":"Nicolas","family":"Degand","sequence":"additional","affiliation":[{"name":"Service de Biologie, CH d\u2019Antibes Juan-les-Pins , Antibes , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emeline","family":"Riverain","sequence":"additional","affiliation":[{"name":"Service de Biologie, GH Yvelines Nord , Mantes-la-Jolie , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lien","family":"Dinh","sequence":"additional","affiliation":[{"name":"Service des Maladies Infectieuses, CHU R. Poincar\u00e9 , Garches , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Timores","sequence":"additional","affiliation":[{"name":"Service de Biologie Clinique, H\u00f4pital Foch , Suresnes , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christel","family":"Mamona","sequence":"additional","affiliation":[{"name":"Service des Maladies Infectieuses, CHU R. Poincar\u00e9 , Garches , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Vall\u00e9e","sequence":"additional","affiliation":[{"name":"Service d'Epid\u00e9miologie-Data-Biostatistiques, D\u00e9l\u00e9gation \u00e0 la Recherche Clinique et \u00e0 l'Innovation, H\u00f4pital Foch , Suresnes , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Vasse","sequence":"additional","affiliation":[{"name":"Service de Biologie Clinique, H\u00f4pital Foch , Suresnes , France"},{"name":"UMRS 1176, le Kremlin-Bic\u00eatre , Paris-Saclay , France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,11,1]]},"reference":[{"key":"2024070805503423500_dlad114-B1","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlaa112","article-title":"CON: carbapenems are NOT necessary for all infections caused by ceftriaxone-resistant Enterobacterales","volume":"3","author":"Rodr\u00edguez-Ba\u00f1o","year":"2021","journal-title":"JAC Antimicrob Resist"},{"key":"2024070805503423500_dlad114-B2","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlac111","article-title":"Temocillin use as a carbapenem-sparing option in a UK teaching hospital for treating serious Gram-negative bacterial infections","volume":"4","author":"Enoch","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"2024070805503423500_dlad114-B3","doi-asserted-by":"crossref","first-page":"115682","DOI":"10.1016\/j.diagmicrobio.2022.115682","article-title":"Temporal evolution of temocillin susceptibility to Enterobacterales in Belgian hospitals, comments on \u2018Temocillin susceptibility among Enterobacterales strains recovered from blood culture in France\u2019","volume":"103","author":"Deyi VY","year":"2022","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2024070805503423500_dlad114-B4","doi-asserted-by":"publisher","first-page":"115368","DOI":"10.1016\/j.diagmicrobio.2021.115368","article-title":"Temocillin susceptibility among Enterobacterales strains recovered from blood culture in France","volume":"100","author":"Farfour","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2024070805503423500_dlad114-B5","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlab192","article-title":"Activity of temocillin against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae bloodstream isolates from a clinical trial","volume":"4","author":"Stewart","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"2024070805503423500_dlad114-B6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/pathogens11030356","article-title":"Antimicrobial resistance in Enterobacterales recovered from urinary tract infections in France","volume":"11","author":"Farfour","year":"2022","journal-title":"Pathogens"},{"key":"2024070805503423500_dlad114-B7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF02148656","article-title":"Interpretive criteria for temocillin disk diffusion susceptibility testing","volume":"4","author":"Fuchs","year":"1985","journal-title":"Eur J Clin Microbiol"},{"key":"2024070805503423500_dlad114-B8","author":"European Committee on Antimicrobial Susceptibility Testing"},{"key":"2024070805503423500_dlad114-B9","author":"Comit\u00e9 de l\u2019antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie"},{"key":"2024070805503423500_dlad114-B10","author":"Comit\u00e9 de l\u2019antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie"},{"key":"2024070805503423500_dlad114-B11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.medmal.2020.07.003","article-title":"Fosfomycin, from susceptibility to resistance: impact of the new guidelines on breakpoints","volume":"50","author":"Farfour","year":"2020","journal-title":"M\u00e9decine Mal Infect"},{"key":"2024070805503423500_dlad114-B12","author":"Haute Autorit\u00e9 de Sant\u00e9","year":"2015"},{"key":"2024070805503423500_dlad114-B13","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlac132\/6964815","article-title":"Real-life temocillin use in Greater Paris area, effectiveness and risk factors for failure in infections caused by ESBL-producing Enterobacterales: a multicentre retrospective study","volume":"5","author":"Dinh","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"2024070805503423500_dlad114-B14","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlab005","article-title":"Clinical outcomes of temocillin use for invasive Enterobacterales infections: a single-centre retrospective analysis","volume":"3","author":"Heard","year":"2021","journal-title":"JAC Antimicrob Resist"},{"key":"2024070805503423500_dlad114-B15","author":"Soci\u00e9t\u00e9 Belge de Maladies Infectieuses et Microbiologie Clinique"},{"key":"2024070805503423500_dlad114-B16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.medmal.2018.03.005","article-title":"Practice guidelines for the management of adult community-acquired urinary tract infections","volume":"48","author":"Caron","year":"2018","journal-title":"Med Mal Infect"},{"key":"2024070805503423500_dlad114-B17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3947\/ic.2018.50.1.67","article-title":"Clinical practice guidelines for the antibiotic treatment of community-acquired urinary tract infections","volume":"50","author":"Kang","year":"2018","journal-title":"Infect Chemother"},{"key":"2024070805503423500_dlad114-B18","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/jac\/dkaa486","article-title":"Efficacy of temocillin against MDR Enterobacterales: a retrospective cohort study","volume":"76","author":"Alexandre","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2024070805503423500_dlad114-B19","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlac086","article-title":"Clinical and microbiological evaluation of temocillin for bloodstream infections with Enterobacterales: a Belgian single-centre retrospective study","volume":"4","author":"Oosterbos","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"2024070805503423500_dlad114-B20","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1093\/jac\/dkt248","article-title":"Temocillin disc diffusion susceptibility testing by EUCAST methodology","volume":"68","author":"Vanstone","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2024070805503423500_dlad114-B21","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1093\/jac\/dky101","article-title":"Temocillin against Enterobacteriaceae isolates from community-acquired urinary tract infections: low rate of resistance and good accuracy of routine susceptibility testing methods","volume":"73","author":"Alexandre","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2024070805503423500_dlad114-B22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/jac\/dkm179","article-title":"Temocillin susceptibility by BSAC methodology","volume":"60","author":"Andrews","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"2024070805503423500_dlad114-B23","author":"European Committee on Antimicrobial Susceptibility Testing"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/5\/6\/dlad114\/58466122\/dlad114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/5\/6\/dlad114\/58466122\/dlad114.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T05:51:03Z","timestamp":1720417863000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/doi\/10.1093\/jacamr\/dlad114\/7336822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlad114","relation":{},"ISSN":["2632-1823"],"issn-type":[{"value":"2632-1823","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12]]},"published":{"date-parts":[[2023,11,1]]},"article-number":"dlad114"}}